Membrane processes 2

[O2.MP-09] Continuous and intensified membrane crystallization process: quality control of an active pharmaceutical ingredient

*Carla Kalakech¹, Élodie CHABANON¹, Sylvaine Sylvaine LAFONT³, Morgane Morgane LE HIR³, David BALTES³, Émilie GAGNIÈRE¹, Denis MANGIN¹, Catherine CHARCOSSET¹, Mathias MONNOT² (1. Claude Bernard Lyon 1 University, 2. Aix Marseille University, CNRS, Centrale Marseille, M2P2, EPM, Marseille, France, 3. Sanofi Chimie, Global Chemistry Manufacturing & Control (CMC), Sisteron, France)

Keywords:Membrane crystallization, Pervaporation, Polymorphism